Myocardial viability - Mechanisms of reversible myocardial dysfunction and diagnosis in coronary artery disease

Cardiovascular Journal of South Africa

Volumn 12, Issue 3, 2001, Pages 169-175

  Goldberg, L ^a   Mekel, J ^a   Landless, P ^a   Smith, D ^a   Grigorov, V ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; THALLIUM 201;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEART MUSCLE PERFUSION; HUMAN; HYPOTENSION; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; SUPRAVENTRICULAR TACHYCARDIA;

CORONARY ARTERIOSCLEROSIS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, STRESS; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; PROGNOSIS;

EID: 0034799298     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
2. American College of Cardiology/American Heart Association Guidelines for Coronary Artery Bypass Graft Surgery
3. The role of coronary revascularisation in the management of heart failure: Identification of candidates and review of results
4. The hibernating myocardium
5. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery function after revascularisation
6. Myocardial hibernation: Adaptation to ischemia
7. Medical and cellular implications of stunning, hibernation and preconditioning
8. Myocardial hibernation vs. repetitive stunning in patients
9. Characterisation of hibernating and stunned myocardium
10. Response to myocardial ischemia as a regulated process
11. Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary revascularization
12. Ultrustructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: Determinants of reversible segmental asynergy postrevascularization surgery
13. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings
14. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from study of noninfarcted collateral-dependent myocardium
15. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism and wall motion in normal and dysfunctional myocardium
16. Myocardial viability: Nuclear medicine versus stress echocardiography
17. Prognostic utility of myocardial viability assessment
18. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging
19. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction
20. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy
21. Postextrasystolic potentiation echocardiography in predicting reversible myocardial dysfunction by surgical coronary revascularisation
22. Myocardial viability in asynergic regions subtended by occluded coronary arteries: Relation to the status of collateral flow in patients with chronic coronary artery disease
23. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q-wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography
24. Collateral circulation as a marker of the presence of viable myocardium in patients with recent myocardial infarction
25. Presence of angiographic coronary collaterals predicts myocardial recovery after coronary bypass surgery in patients with severe left ventricular dysfunction
26. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction
27. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases
28. Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in predicting of wall motion recovery after revascularisation
29. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201-T1 tomography versus dobutamine echocardiography
30. Correlation of preoperative myocardial function, perfusion and metabolism with postoperative function at rest and stress after bypass surgery in severe left ventricular dysfunction
31. Quantitative analysis of technetium-99m 2-methoxyisobutyl-isonitrale single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularisation
32. Rest Technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reability for prediction of revascularisation outcome of asynergic territories
33. Detection of viable myocardium by dobutamine and dipyridamole
34. Relation between myocardial injury and postextrasystolic potentiation of regional function measured by two-dimensional echocardiography
35. Intraoperative evaluation of myocardial viability by nitroglycerin-induced improvement in regional left ventricular function assessed by transesophageal echocardiography
36. Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography
37. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularisation in chronic ischemic heart disease
38. Searching for hibernating myocardium. Time to reevaluate investigative strategies
39. Identification of viable myocardium
40. Assessment of myocardial viability by dobutamine echocardiography, PET and thallium-201 SPECT
41. Relation between thallium uptake and contractile response to dobutamine
42. 'Hibernating' myocardium: Asleep or part dead?
43. Assessment of myocardial viability in chronic coronary artery disease using Technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up
44. There may be more viability than meets eye!
45. The viable myocardium: Epidemiology, detection and clinical implications
46. Morphological and echocardiographic features of viable and nonviable myocardium
47. Evolution of dobutamine echocardiography protocols and indications: Safety and side-effects in 3 011 studies over 5 years
48. Coronary artery bypass surgery as treatment for ischemic heart failure: The predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome
49. Quantitative planar rest-redistribution 201 T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function
50. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability